News | March 23, 2022
Thyssenkrupp bags order for a pharma-grade SFE plant for solids extraction
The scope of supply includes the skid-mounted plant as well as on-site installation and commissioning support
The scope of supply includes the skid-mounted plant as well as on-site installation and commissioning support
Novartis data again demonstrate age-appropriate development when Zolgensma is used presymptomatically, and post-hoc data reveal SMA Type 1 patients could speak, swallow and maintain airway protection
The new plant at Slovenská ?up?a site in Slovakia is scheduled to come on stream in two years
Covaxin has proven to be safe, well-tolerated, and immunogenic in paediatric subjects in phase II/III study. Neutralizing antibodies in children on an average 1.7 times higher than in adults
Achondroplasia is a genetic condition that causes severely short stature and disproportionate growth
The preregistrations are aimed at registering both healthy children and those with comorbidities whereas preference will be given for children with comorbidities
The list of kids with co-morbidities eligible for vaccination would be announced by the government
_256_384.jpg)
The two doses of Covaxin are likely to be administered to children with a gap of 28 days
Over 70 per cent of the world’s population have no access to MRI scanners and the situation is not that encouraging in India where there are only 0.4 MRI scanners per thousand people
New Phase III data on gefurulimab highlight potential as a self-administered treatment option; real-world evidence reinforces clinical benefits of Ultomiris and Soliris
Subscribe To Our Newsletter & Stay Updated
